Next Article in Journal
Sustainable Approach of Functional Biomaterials–Tissue Engineering for Skin Burn Treatment: A Comprehensive Review
Next Article in Special Issue
Transient Coatings from Nanoparticles Achieving Broad-Spectrum and High Antimicrobial Performance
Previous Article in Journal
Comprehensive Characterization of a Streptococcus agalactiae Phage Isolated from a Tilapia Farm in Selangor, Malaysia, and Its Potential for Phage Therapy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Aggregation, Cytotoxicity and DNA Binding in a Series of Calix[4]arene Amphiphile Containing Aminotriazole Groups

1
Alexander Butlerov Institute of Chemistry, Kazan Federal University, 18 Kremlevskaya Str., 420008 Kazan, Russia
2
Interdisciplinary Center for Analytical Microscopy, Kazan Federal University, 18 Kremlevskaya Str., 420008 Kazan, Russia
3
Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlevskaya Str., 420008 Kazan, Russia
4
Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of RAS, 8 Arbuzov Str., 420088 Kazan, Russia
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2023, 16(5), 699; https://doi.org/10.3390/ph16050699
Submission received: 11 April 2023 / Revised: 24 April 2023 / Accepted: 3 May 2023 / Published: 5 May 2023
(This article belongs to the Special Issue Self-Assembled Nanoparticles: An Emerging Delivery Platform for Drugs)

Abstract

:
The present work focuses on the study of the aggregation and complexing properties of calixarenes as potential DNA condensation agents for gene delivery. In the current study, 1,4-triazole derivatives of calix[4]arenes 7 and 8 containing monoammonium fragments were synthesized. The synthesized compound’s structure was characterized by using various spectroscopic techniques (FTIR, HRESI MS, ¹H NMR and ¹³C NMR). The interactions between a series of calix[4]arene-containing aminotriazole groups (triazole-containing macrocycles with diethylenetriammonium fragments (3 and 4) and triazole-containing macrocycles with monoammonium fragments (7 and 8)) and calf thymus DNA were carried out via UV absorption, fluorescence spectroscopy, dynamic light scattering and zeta potential measurements. The role of the binding forces of calixarene–DNA complexes was analyzed. Photophysical and morphological studies revealed the interaction of the calixarenes 3, 4 and 8 with ct-DNA, which transformed the fibrous structure of ct-DNA to completely condensed compact structures that are 50 nm in diameter. The cytotoxic properties of calixarenes 3, 4, 7 and 8 against cancerous cells (MCF7, PC-3) as well as a healthy cell line (HSF) were investigated. Compound 4 was found to have the highest toxic effect on MCF7 breast adenocarcinoma (IC50 3.3 μM).

Graphical Abstract

1. Introduction

One of the rapidly developing areas of research in supramolecular chemistry and nanotechnology is the design of systems suitable for numerous applications. Among the wide variety of macrocycles, calixarenes stand out for their ease of functionalization, which allows the introduction of different groups along the upper and/or lower rims [1]. This has led to calixarenes being used in biomedical fields as biocatalysts [2] and anti-tumor agents [3,4], and they have shown excellent antibacterial [5,6,7], antifungal [8,9] and anticancer properties [10,11,12,13]. Calixarenes can exhibit amphiphilic properties when phenolic rings are functionalized with ionic groups and alkyl substituents. This allows calixarenes to establish multiple and cooperative noncovalent interactions—for instance, to transform the deoxyribonucleic acid into a compact form. Thus, the efficiency of several calixarenes as condensing agents has been reported [14,15]. Additionally, calixarenes are excellent host macrocyclic compounds. Their flexible structural properties can help host different guest species, either neutral organics or ionic compounds [16]. Moreover, their capacity to form aggregates allows for the preparation of nanocarriers for different drugs [17,18,19]. Thus, the design of systems based on calixarenes compatible with the biological area and for applications in drug delivery, binding and the detection of biomolecules is an important task. A special place in calixarenes for bioapplications is occupied by aminocalixarenes. They are known to effectively interact with the negatively charged DNA phosphate backbone [20]. It was also reported that the formulation of amphiphilic aminocalix[4]arene-based solid lipid nanoparticles with DNA and chitosan can transfect mammalian cells [21]. According to the data [22], amino-substituted amphiphilic calixarenes have the potential to achieve a targeted delivery of paclitaxel to tumor tissues. Taking into account the relevance of the aggregation properties of calixarenes upon interaction with various biologically active compounds and drugs, in this paper, we report the synthesis of novel water-soluble calix[4]arene amphiphile-containing aminotriazole groups in a preliminary investigation of their potential application in biological fields.

2. Results and Discussion

2.1. Synthesis

Previously, our research group developed a strategy for the synthesis of tetra-azide derivatives of calix[4]arenes with tetradecyl alkyl chain substitutes 1 and free hydroxyl groups on the lower rim 2 (Scheme 1), and triazole-containing macrocycles with diethylenetriammonium fragments 3 and 4 were obtained [23,24].
In this work, to study the effect of the number of amino groups on the binding abilities toward DNA, we synthesized 1,4-triazole derivatives of calix[4]arenes containing four ammonium fragments. For this, macrocycles 1 and 2 were introduced into the reaction of azide-alkyne cycloaddition (CuAAC) with N-propargylphatilimide in toluene (Scheme 2) at 40 °C for 24 h using a copper iodide(I)-triethylamine catalytic system. The reaction with the unsubstituted at the lower rim macrocycle 2 was carried out with the addition of DMF to increase the solubility of the initial substrate. Target products 5 and 6 were isolated in 70% and 89% yields, respectively.
In the 1H NMR-spectra of compound 5, the proton signals of the triazole and aromatic fragments appeared as two singlets at 7.75 and 7.01 ppm, respectively (Figure S1a). Two doublets of doublets at 7.80 and 7.68 ppm with the coupling constants J = 3.1 and 5.4 Hz, respectively, corresponded to the proton signals of the phthalimide substituent, and a singlet at 5.01 ppm belonged to the methylene group, bridged to the triazole fragment. The protons of the tetradecyl substituent appeared at 3.94 and 0.87 (triplets), 1.91 (multiplet) and 1.66 and 1.38 (broadened singlets). The successful introduction of the phthalimide fragment into the structure of macrocycle is evidenced by the appearance of an absorption band of the C=O group at 1717 cm−1 in the FTIR-spectra (Figure S1b) and in the 13C NMR-spectra of the signal of its carbonyl carbon at 167.80 ppm (Figure S1c). The presence in HRESI MS-spectra [M+H]+, [M+2H]2+ ions with m/z 2115.2503 and 1058.1295, respectively (theoretical 2115.2508 and 1058.1290, respectively) unambiguously prove the composition of 5. The appearance of the proton signals of the triazole and phthalimide fragments at 8.39 and 7.87 ppm as a singlet and a multiplet, respectively, in the 1H NMR spectra (Figure S2a) indicates the conversion of the target product 6. The proton signals of the calixarene platform appeared as two singlets at 7.61 (aromatic) and 3.55 ppm (bridged methylene groups); for the CH2-group between triazole and phthalimide, it appeared at 4.84 ppm. In the FTIR spectra (Figure S2b), similar to compound 5, the absorption band of the C=O group at 1712 cm−1 was discovered. HRESI MS-spectra (Figure S2d) in a positive regime showed the ion [M+H]+ with m/z 1329.3704 (theoretical 1329.3710), which confirms the structure of 6.
Phthalimide protection was removed by reacting macrocycles 5 and 6 with hydrazine hydrate in methanol. After treatment with hydrochloric acid solution and subsequent precipitation, calix[4]arenes 7 and 8 were isolated in 72% and 90% yields, respectively.
In the 1H NMR-spectra (Figure S3a) of compound 7, the composition of the target product is evidenced by the disappearance of signals from the protons of the phthalimide fragment. The strong broadening of all proton signals was due to the aggregation of the macrocycle in deuterosolvents. Singlets at 7.71 and 7.07 ppm corresponded to the proton signals of triazole and aromatic rings, respectively. In addition, the signals of N-CH2 and O-CH2 protons overlapped in the spectra, which led to a broadened singlet at 3.97 ppm with an integral intensity equal to ~16. The remaining signals were correlated according to the structure of calixarene. Taking into account four amino groups in the molecule of macrocycle 7, multiply charged ions were observed in the HRESI MS-spectra (Figure S3d) in a positive regime: [M+H]+, [M+2H]2+ and [M+3H]3+ with m/z 1595.2221, 798.1186 and 532.4148, respectively (theoretical 1595.2289, 798.1181 and 532.4151, respectively).
The 1H NMR-spectra of compound 8 (Figure S4a) were registered in deuterium oxide due to its great solubility in water. Peaks were found in the spectra at 8.27, 7.49 and 4.21 ppm, which were related to the proton signals of the triazole ring, aromatic fragment and aminomethylene group, respectively. The signals of the bridged methylene groups overlapped with the signal of the solvent and appeared as a singlet, which is consistent with the general theory for macrocycles unsubstituted at the lower rim: the polar solvent participates with OH-groups in the formation of hydrogen bonds, which leads to an increase in the conformational mobility of calixarene in solution [25]. For the same reason, the carbon signals in the 13C NMR spectra (Figure S4b) were strongly broadened. Even lowering the temperature to 5 °C did not narrow the signals. In the FTIR-spectra, a broad absorption band at 2925 cm−1 was characteristic, reflecting the stretching vibrations of OH-, CHar and NH3+-groups (Figure S4c). Despite the presence of four charged amino groups in the structure of macrocycle 8, only ions [M+H]+ and [M+2H]2+ with m/z 809.3482 and 405.177, respectively (theoretical 809.3491 and 405.1782, respectively) were observed in the mass-spectra (Figure S4d).

2.2. Study of the Self-Assembly of Calixarenes

2.2.1. Determination of the Critical Aggregate Concentration (CAC)

The CAC of calixarenes was determined by using pyrene as a probe [26] (Figure S5). The values of CAC for the calixarenes studied are listed in Table 1. The CAC values for the 4 and 8 calixarenes cannot be determined, as the structures of these macrocycles lack lipophilic fragments that contribute to spontaneous association into aggregates. For 3, the CAC value was slightly higher than for 7. The prevention of the early aggregation of 3 compared to 7 was due to the larger volume and total charge of hydrophilic groups in 3.

2.2.2. Determination of the Size and Zeta Potential of Calixarenes

In Table 1, the average diameters of the nanostructures measured by using the dynamic light scattering method (DLS) are presented. Particle sizes at concentrations above CAC (10 μM) were determined. In addition, in Table 1, the polydispersity indices (PDI) for studied systems are assembled. Despite the bulk hydrophilic groups on the upper rim, 3 at concentrations above CAC predominantly formed aggregates with an average hydrodynamic diameter of 20 nm.

2.3. Interaction of Calixarenes with DNA

2.3.1. Absorption Spectroscopy Measurements

The UV-vis absorption spectrum of ct-DNA with absorption maximum at 260 nm reveals a broad band (Figure 1). As a result of conformational changes in the DNA structure upon interaction with calixarenes’ red/blue shift, hyperchromic/hypochromic effects in UV-vis spectra could be observed. The addition of 7, 4 and 3 to ct-DNA solution led to an increase in the hyperchromic effect. For 8, a hypochromic effect and a slight bathochromic shift of the calixarene absorption maximum were observed. For 3, the maximum hyperchromic effect was fixed. Therefore, ct-DNA double strands were folded simultaneously due to assembly interactions, such as hydrophobic effects and hydrogen bonds between the corresponding bases. Thus, the hyperchromic effect was due to the presence of a charged cationic fragment of the calixarene, which interacted with the phosphate group of the DNA backbone through the Coulomb interaction.

2.3.2. DNA Melting Temperature (Tm) Study

The temperature increases lead to the denaturation of dsDNA into single-stranded DNA (ssDNA) due to the weakening of base and hydrogen bond interactions. Changes in the structure of the DNA molecules led to changes in their conformation and physical properties (absorption and melting point). The DNA melting temperature (Tm) is defined as the temperature at which half of the double-helical DNA structure is unfolded to two individual strands [27]. On one hand, strong intercalation can stabilize the double helix of DNA, resulting in a 5–10 °C increase in Tm. On the other hand, for groove or Coulomb binding, the change in Tm is negligible [28]. The Tm values were calculated from the melting curve (Figure 2). For free ct-DNA, Tm was 73.1 °C, whereas in the presence of calixarenes 3, 4, 7 and 8, it was found to be 84.1 °C, 75.2 °C, 74.1 °C and 75.0 °C, respectively. Strong changes in Tm values for ct-DNA in the presence of poly amino derivatives of calixarene (3 and 4) indicate the strong intercalation between calixarenes and ct-DNA.

2.3.3. Fluorescence Spectroscopic Studies—Competitive Displacement Assay

The competitive binding of EtBr (ethidium bromide) and calixarenes to ct-DNA was used to quantify interactions between DNA and the calixarenes by using fluorescence emission spectroscopy. The EtBr fluorescence intensity increased significantly when intercalated into base pairs of ct-DNA. However, the addition of calixarenes displaced the EtBr from DNA, which resulted in fluorescence quenching. Calixarenes displaced EtBr from the ct-DNA in a concentration-dependent manner but with various curve profiles. The concentration increased for calixarenes with alkyl substituents on the lower rim (3 and 7) in DNA solution, resulting in a smooth quenching fluorescence emission from EtBr (Figure 3c,d). Additionally, the 3 and 8 in DNA solutions in the range of 10–15 μM led to strong changes in the quenching of the EtBr emission (Figure 3a,b). This phenomenon was associated with a change in the mechanism of interaction between calixarene and DNA. It may have been the result of the formation of DNA/calixarene complexes other than in a 1:1 ratio. The formation of complexes of different compositions led to a redistribution of electron density, which in turn strongly changed the quantum yield of the fluorescence emissions.
For the quantification of intermolecular interactions between calixarenes with EtBr-DNA systems, the well-known Stern–Volmer plots were used according to Equation (1):
F 0 F = 1 + K S V Q = 1 + k q + τ 0 [ Q ] ,
where F0 and F represent the emission intensities of EtBr-DNA without and with calixarenes, respectively, and KSV represents the quenching constant. k q and τ 0 are the bimolecular quenching rate constant and fluorescence lifetime without quenching ( τ 0 = 10 8 s), respectively. The evaluated quenching constant ( K S V values) also designates that calixarenes 3, 4 and 8 bind to ct-DNA (Table 2). According to Equation (1), Kq is higher than the limiting diffusion rate constant ( 2 × 10 10 M 1 s 1 ) for a biomacromolecule, indicating the existence of a static quenching mechanism [29].
The binding constant (Kb) and the stoichiometry of binding (n) per DNA molecule were computed from the intercept and slope of the plot of l o g ( F 0 F ) / F versus log (calixarene), as shown in (Figure 4b) and Table 2, using Equation (2):
l o g F 0 F F = l o g K b + n l o g C ,
where K b is the binding constant and n is the number of binding sites. For all studies of systems and calixarenes in DNA solution, except 7, the binding constants and number of bindings cites were close to each other. The results obtained for 3, 4 and 8 in DNA solution indicates the same mechanisms of interaction realized in studied systems in a low concentration range. In the case of 7, the estimation of the binding constant with DNA is not possible due to the low-quality dependence between the emission fluorescence of DNA and the concentration of calixarene. The reason for this can be related to the strong self-association of 7, which prevents its interaction with DNA.
The binding force between protein and ligand complexes is noncovalent bonds, which can be divided into hydrogen bonds, hydrophobic forces, Columbic interactions and van der Waals interactions. For estimation of the thermodynamic parameters, a linear van’t Hoff plot between binding constants and inverse temperature was applied (see Figure S6).
l n K = H R T + S R
Δ G = Δ H T Δ S ,
From the van’t Hoff plot, the thermodynamics parameters of the binding ligand–protein complexes were calculated, and they are assembled in Table 3. The change in the negative value of free energy suggests that the interaction between calixarenes and DNA was spontaneous and feasible. The negative values of enthalpy change explored that the van der Waals interaction along with the hydrogen bonds were the major binding forces involved in the protein–ligand complexes [30].

2.3.4. Particle Size and Zeta Potential Measurements

The dynamic light scattering method (DLS) is a common technique for studying changes of particle size and zeta potentials of DNA complexes with calixarenes at different concentrations. In Figure 5, the obtained results are presented. The addition of calixarenes 3, 4 and 8 to DNA at a calixarene concentration of 5 μM led to the compactization of DNA from 562 nm to 150–100 nm and low values of the polydispersity index (Figure S6). Previously [24], it was shown that the addition of calixarenes 3 and 4 to DNA does not cause changes in the native DNA structure, according to the circular dichroism (CD) method. The addition of calixarene 7 to DNA did not significantly decrease the average hydrodynamic diameter of the calixarene–DNA double system, even at an equimolar ratio of 1:1 (50 μM) (Figure 5a).
The addition of calixarenes 3, 4 and 8 caused the gradual neutralization of negative DNA charges (Figure 5b). Thus, the calixarenes led first to electrostatic binding, and in the case of 3, to DNA immersion into aggregates, which caused the increase of the zeta potential of calixarene–DNA systems to positive values. The addition of calixarene 7 to DNA practically had no effect on the zeta potential of DNA.

2.3.5. Transmission Electron Microscopy (TEM)

The surface morphology of the calixarene–DNA systems was observed by using TEM. In Figure 6, the structures of free DNA and DNA in the presence of calixarenes are presented. Images of free DNA show typical fibril-like structures [31]. The highly condensed structures generated after the addition of calixarenes in DNA solution are shown in Figure 6b–d.
In Figure 6, the formation of gorgon-like aggregates between 4 and 8 with DNA was found. This indicates that 4 and 8 do not form intramolecular DNA condensates. However, simultaneously, the interaction of 4 and 8 with several DNA strands could be what generated the observed gorgon-like aggregates (Figure 6b,c). In this case, electrostatic interactions between the positively charged upper rim groups of 4 and 8 and negatively charged DNA bases are dominant. For lipophilic 3, the compactization of DNA into vesicle-like aggregates was observed. For calixarene 7, no usable samples could be obtained.

2.4. Cytotoxicity Analysis of Calixarenes

During the dissolution of the compounds, we found that compound 7 was poorly soluble in water up to a concentration of 20 mM, unlike other studied compounds. Therefore, we decided to decrease the concentration of compound 7 to 5 mM (although the formation of clots was observed, which dissolved upon heating to 100 °C). In addition, during the serial dilution of compounds in the culture medium, the formation of insoluble precipitates was observed. They were especially clearly visible at concentrations of 320 µM and 640 µM. These clots gave a false positive result during the MTT-test. Therefore, it was not possible to reliably determine the degree of influence of the studied compounds at concentrations of 320 µM and 640 µM. Thus, it was decided not to take into account these concentrations, and therefore, the concentration range shown on the graph is up to 160 µM (Figure 7).
We found that calixarene 4 exhibited greater cytotoxic activity against MCF7 breast adenocarcinoma and PC-3 prostate carcinoma (Table 4). The minimal cytotoxicity of calixarene 4 against normal HSF cell lines was observed. The values in the semimaximal inhibition range for calixarene 4 from 3 µM to 109 µM. Calixarene 3 exhibited cytotoxic activity against MCF7 breast adenocarcinoma at the same values as for calixarene 4 (Table 4). However, for calixarene 3, cytotoxicity against normal HSF cell lines was also observed. For compound 7, cytotoxic activity was also observed against the PC-3 cell line (IC50—108 µM) (Table 4). The IC50 values for compound 8 could not be determined within the studied concentration range. The results obtained for calixarene 4 correlate with the IC50 values obtained for the amine-containing calix[4]arene [32]. However, the presence of triazole groups on the upper rim and OH groups on the lower rim allowed for increased selectivity towards MCF7 compared to healthy cells. Nevertheless, more studies are needed to confirm this lack of selectivity and to compare its effects with anticancer agents in clinical use.

3. Materials and Methods

3.1. Characterization Methods

1H and 13C NMR spectra as well as 2D 1H-1H NOESY were recorded on Bruker Avance 400 Nanobay (Bruker Corporation, Billerica, MA, USA) with signals from residual protons of CDCl3, D2O or DMSO-d6 as the internal standard.
The melting points were measured using the Optimelt MPA100 melting point apparatus (Stanford Research Systems, Sunnyvale, CA, USA).
IR spectra in KBr pellets were recorded on a Bruker Vector-22 spectrometer (Bruker Corporation, Billerica, MA, USA).
High-resolution mass spectra with electrospray ionization (HRESIMS) were obtained on an Agilent iFunnel 6550 Q-TOF LC/MS (Agilent Technologies, Santa Clara, CA, USA) in positive or negative mode with the following parameters: nitrogen carrier gas; temperature, 300 °C; carrier flow rate, 12 L × min−1; nebulizer pressure, 275 kPa; funnel voltage, 3500 V; capillary voltage, 500 V; total ion current recording mode; 100–3000 m/z mass range; scanning speed, 7 spectra × s−1.

3.2. Materials

Materials of the highest purity available were purchased from Fluka and Sigma-Aldrich and used as received. Solvents were purified according to standard methods. 3-Bis[2-(tertbutoxycarbonylamino)ethyl]propargylamine, 25,26,27,28-tetrahydroxycalix[4]arene, 5,11,17,23-tetraazo-25,26,27,28-tetrahydroxycalix[4]arene, 5,11,17,23-tetraamino-25,26,27,28-tetrahydroxycalix[4]arene [33,34,35] and 5,11,17,23-tetraazido-25,26,27,28-tetrahydroxycalix[4]arene, 5,11,17,23-tetraazido-25,26,27,28-tetratetradecyloxycalix[4]arene [23,24] were prepared following procedures in the literature.

Synthesis

The 5,11,17,23-tetra(4-phtalimidomethyl-1,2,3-triazol-1-yl)-25,26,27,28-tetratetradecyloxycalix[4]arene (5), synthesis of 5,11,17,23-tetra(4-phtalimidomethyl-1,2,3-triazol-1-yl)-25,26,27,28-tetrahydroxycalix[4]arene (6), 5,11,17,23-tetra(4-aminomethyl-1,2,3-triazol-1-yl)-25,26,27,28-tetratetradecyloxycalix[4]arene tetrahydrochloride (7) and 5,11,17,23-tetra(4-aminomethyl-1,2,3-triazol-1-yl)-25,26,27,28-tetrahydroxycalix[4]arene tetrahydrochloride (8) were synthesized according to previously developed methods with minor modifications [24]. Detailed descriptions of the synthesis procedures are present in the Supplementary Materials.

3.3. Sample Preparation

All solutions were prepared with Adrona Crystal E30 MilliQ water, resistivity 0.055 microSiemens (SIA «Adrona», Latvia, Riga). The highly concentrated solutions of macrocycles (1 mM) and EtBr (1 mM) were prepared in water. The pH levels of the solutions were maintained at 7.4 by using 10 mM TRIS-HCl (tris(hydroxymethyl)aminomethane) buffer. Amounts of ct-DNA were dissolved in 10 mM Tris-HCl buffer (pH 7.4) and kept at 4 °C for 24 h. Calf thymus DNA concentration was evaluated by using a previously developed approach [36].

3.4. UV Absorption Spectroscopic Study

The UV-Vis spectra were recorded by using spectrophotometer Shimadzu UV-2600 (Shimadzu, Kyoto, Japan). The spectra were recorded between 240 and 320 nm using a quartz cuvette of path length 1 cm.

3.5. Steady-State Fluorescence Study

The emission spectra were recorded by using spectrofluorometer Jobin Yvon Horiba Fluorolog-3 (HORIBA Jobin Yvon SAS, France). Fluorescence emissions were registered in the range of 535–750 nm with excitation at 525 nm and a 3 nm slit. The CAC values were measured according to the method presented in [24].

3.6. Dynamic and Electrophoretic Light Scattering Study

DLS and ELS measurements were carried out on a Zetasizer Nano ZS instrument (Malvern Panalytical, UK) with a 4 mW 633 nm He–Ne laser light source and a light scattering angle of 173 degrees. The solutions were filtered through an 800 nm filter before measurements to remove dust.

3.7. Transition Electron Microscopy (TEM) Study

TEM was performed on a Hitachi HT7700 ExaLens (Hitachi High-Tech Corporation, Tokyo, Japan). Sample preparation was performed using a previously developed method [24].

3.8. Cell Culture Cultivating

Tumor cell lines MCF7 (breast adenocarcinoma) and PC-3 (prostate carcinoma) were cultured in DMEM media with the addition of 5% inactivated fetal bovine serum, 1 mM L-glutamine and a mixture of penicillin (5000 U/mL) and streptomycin (5000 µg/mL). The HSF cell line (human skin fibroblasts) was cultured in DMEM media with the addition of 10% inactivated fetal bovine serum, 1 mM L–glutamine and a mixture of penicillin (5000 U/mL) and streptomycin (5000 µg/mL). The cells were cultured at 37 °C in a humid atmosphere containing 5% CO2.
The cells were placed in 96-well culture plates with a flat bottom at a concentration of 4 × 103 cells per well (for PC-3 and MCF7) and 5 × 103 cells per well (for HSF) in a full culture medium and incubated at 37 °C with 5% CO2 for 24 h.

3.9. Addition of the Studied Compounds to Cells

Stock solutions of the compounds were prepared before the experiment by dissolving the compounds in deionized water to final concentrations of 20 mM (3, 4 and 8) and 5 mM (7). The compounds were added to the wells with cells to obtain final concentrations of 5 µM, 10 µM, 20 µM, 40 µM, 80 µM, 160 µM, 320 µM and 640 µM. Equal volumes of medium were added to untreated cells (control).

3.10. Cytotoxicity Analysis of the Compounds

The cytotoxicity of the compounds in tumor cell lines was analyzed using a colorimetric MTT-test, and the results were detected using microplate reader Infinite M200 (Tecan, Männedorf, Switzerland). The cytotoxicity of the studied compounds was analyzed in 3 technical and 2 biological replicates.
The cytotoxicity of the studied compounds was determined using the MTT assay, a colorimetric assay for assessing the metabolic activity of cells. Briefly, yellow tetrazole was reduced to insoluble purple formazan in living cells. A solvent (usually dimethyl sulfoxide) was added to convert the insoluble purple formazan to a colored solution. The absorbance of this colored solution can be expressed quantitatively by measuring it at a specific wavelength (usually between 500 and 600 nm) using spectrophotometry.
MTT reagent was added at the end of the experiment to analyze the number of live cells. The incubation of cells with MTT reagent took 4 h, whereas the division cycle of a tumor cell was ~12 h. Therefore, the effect of MTT on the proliferative activity of cells was insignificant. A more detailed description of the experimental procedure is present in the Supplementary Materials.

4. Conclusions

In this work, triazole-containing calix[4]arene with monoammonium fragments was synthesized. The ct-DNA binding, subsequent DNA condensation and cytotoxicity studies of series of calix[4]arene amphiphile-containing aminotriazole groups using optical, morphological and MTT assay techniques was demonstrated. The results of the DLS and TEM methods indicate the process of DNA condensation. The role of positively charged upper rim groups of calixarenes in controlling the process of DNA condensation was confirmed by using zeta-potential measurements. It is shown that electrostatic interaction and intercalation induces efficient DNA condensation via calixarene molecules. The dominant contribution of hydrogen bonds in the complex formation between calixarene and DNA is established. The in vitro biological applicability of calixarene-containing aminotriazole groups tested by performing an MTT assay on cancer and normal cells revealed greater toxicity to cancer cells than to healthy cells. The present study contributes to a better understanding of the factors affecting DNA macrocycle binding and may help to develop more effective and safer vectors for gene therapy.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ph16050699/s1, characterization methods, syntheses procedure, Figure S1: NMR 1H (a), FTIR (b), 13C (c) and ESI (d) spectra of 5,11,17,23-tetra(4-phtalimidomethyl-1,2,3-triazol-1-yl)-25,26,27,28-tetratetradecyloxycalix[4]arene (5); Figure S2: NMR 1H (a), FTIR (b), 13C (c) and HRESI MS (d) spectra of 5,11,17,23-tetra(4-phtalimidomethyl-1,2,3-triazol-1-yl)-25,26,27,28-tetrahydroxycalix[4]arene (6); Figure S3: NMR 1H (a), 13C (b), FTIR (c) and ESI (d) spectra of 5,11,17,23-tetra(4-aminomethyl-1,2,3-triazol-1-yl)-25,26,27,28-tetratetradecyloxycalix[4]arene tetrahydrochloride; Figure S4: NMR 1H (a), 13C (b), FT IR (c) and HRESI MS (d) spectra of 5,11,17,23-tetra(4-aminomethyl-1,2,3-triazol-1-yl)-25,26,27,28-tetrahydroxycalix[4]arene tetrahydrochloride; Figure S5: Dependence of the ratios of the first and third pyrene emission peaks on the logarithm of the concentration of macrocycles 3 and 7; Figure S6: The van’t Hoff plot of ln Kb versus 1/T; Figure S7: DLS intensity vs diameter graph for solutions of ct-DNA (A) and ct-DNA with 3 (B), 4 (C), 7 (D) and 8 (E) after a colorimetric MTT-test procedure.

Author Contributions

Conceptualization, V.B. and D.M.; methodology, V.B.; software, V.E., validation, S.S., I.A. and D.M.; formal analysis, D.M.; investigation, E.M., K.A., I.B., D.M., V.E., D.D., E.G. and E.B.; resources, V.B.; data curation, V.E., E.B. and D.M.; writing—original draft preparation, D.M.; writing—review and editing, I.A.; visualization, E.S.; project administration, V.B.; funding acquisition, V.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Russian Science Foundation (grant No. 21-73-10062).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article or the Supplementary Materials.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Neri, P.S.; Sessler, J.L.; Wang, M.-X. Calixarenes and Beyond; Springer: New York, NY, USA, 2016. [Google Scholar] [CrossRef]
  2. Bilal, M.; Fernandes, C.D.; Mehmood, T.; Nadeem, F.; Tabassam, Q.; Ferreira, L.F.R. Immobilized lipases-based nano-biocatalytic systems—A versatile platform with incredible biotechnological potential. Int. J. Biol. Macromol. 2021, 175, 108–122. [Google Scholar] [CrossRef]
  3. Basilotta, R.; Mannino, D.; Filippone, A.; Casili, G.; Prestifilippo, A.; Colarossi, L.; Raciti, G.; Esposito, E.; Campolo, M. Role of Calixarene in Chemotherapy Delivery Strategies. Molecules 2021, 26, 3963. [Google Scholar] [CrossRef]
  4. An, L.; Wang, C.; Zheng, Y.-G.; Liu, J.-d.; Huang, T.-h. Design, synthesis and evaluation of calix[4]arene-based carbonyl amide derivatives with antitumor activities. Eur. J. Med. Chem. 2021, 210, 112984. [Google Scholar] [CrossRef]
  5. Shurpik, D.N.; Padnya, P.L.; Stoikov, I.I.; Cragg, P.J. Antimicrobial Activity of Calixarenes and Related Macrocycles. Molecules 2020, 25, 5145. [Google Scholar] [CrossRef]
  6. Fang, S.; Dang, Y.-Y.; Li, H.; Li, H.; Liu, J.; Zhong, R.; Chen, Y.; Liu, S.; Lin, S. Membrane-Active Antibacterial Agents Based on Calix[4]arene Derivatives: Synthesis and Biological Evaluation. Front. Chem. 2022, 10, 816741. [Google Scholar] [CrossRef]
  7. Ali, Y.; Muhamad Bunnori, N.; Susanti, D.; Muhammad Alhassan, A.; Abd Hamid, S. Synthesis, in-Vitro and in Silico Studies of Azo-Based Calix[4]arenes as Antibacterial Agent and Neuraminidase Inhibitor: A New Look Into an Old Scaffold. Front. Chem. 2018, 6, 210. [Google Scholar] [CrossRef] [PubMed]
  8. Muneer, S.; Memon, S.; Pahnwar, Q.K.; Bhatti, A.A.; Khokhar, T.S. Synthesis and investigation of antimicrobial properties of pyrrolidine appended calix[4]arene. J. Anal. Sci. Technol. 2017, 8, 3. [Google Scholar] [CrossRef]
  9. Dono Gezelbash, Z.; Akbari Dilmaghani, K. Synthesis, antifungal and antibacterial activity of calix[4]arene-based 1,3,4-oxadiazole derivatives. J. Chin. Chem. Soc. 2020, 67, 1446–1452. [Google Scholar] [CrossRef]
  10. Geraci, C.; Consoli, G.M.L.; Galante, E.; Bousquet, E.; Pappalardo, M.; Spadaro, A. Calix[4]arene Decorated with Four Tn Antigen Glycomimetic Units and P3CS Immunoadjuvant: Synthesis, Characterization, and Anticancer Immunological Evaluation. Bioconjug. Chem. 2008, 19, 751–758. [Google Scholar] [CrossRef]
  11. Da Silva, D.L.; Silva Terra, B.; Ribeiro Lage, M.; Lúcia Tasca Góis Ruiz, A.; Capeletti da Silva, C.; Ernesto de Carvalho, J.; Walkimar de Mesquita Carneiro, J.; Terra Martins, F.; Antonio Fernades, S.; de Fátima, Â. Xanthenones: Calixarenes-catalyzed syntheses, anticancer activity and QSAR studies. Org. Biomol. Chem. 2015, 13, 3280–3287. [Google Scholar] [CrossRef]
  12. Oguz, M.; Yildirim, A.; Durmus, I.M.; Karakurt, S.; Yilmaz, M. Synthesis of new calix[4]arene derivatives and evaluation of their cytotoxic activity. Med. Chem. Res. 2022, 31, 52–59. [Google Scholar] [CrossRef]
  13. Läppchen, T.; Dings, R.P.M.; Rossin, R.; Simon, J.F.; Visser, T.J.; Bakker, M.; Walhe, P.; van Mourik, T.; Donato, K.; van Beijnum, J.R.; et al. Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[18F]fluoroethylazide, and in vivo evaluation. Eur. J. Med. Chem. 2015, 89, 279–295. [Google Scholar] [CrossRef] [PubMed]
  14. Sansone, F.; Dudič, M.; Donofrio, G.; Rivetti, C.; Baldini, L.; Casnati, A.; Cellai, S.; Ungaro, R. DNA Condensation and Cell Transfection Properties of Guanidinium Calixarenes:  Dependence on Macrocycle Lipophilicity, Size, and Conformation. J. Am. Chem. Soc. 2006, 128, 14528–14536. [Google Scholar] [CrossRef]
  15. Ibragimova, R.R.; Burilov, V.A.; Aimetdinov, A.; Mironova, D.; Evtugyn, V.; Osin, Y.; Solovieva, S.; Antipin, I. Polycationic Derivatives of p-tert-Butylthiacalix[4]arene in 1,3-alternate Stereoisomeric Form: New DNA Condensing Agents. Macroheterocycles 2016, 9, 433–441. [Google Scholar] [CrossRef]
  16. Español, E.S.; Villamil, M.M. Calixarenes: Generalities and Their Role in Improving the Solubility, Biocompatibility, Stability, Bioavailability, Detection, and Transport of Biomolecules. Biomolecules 2019, 9, 90. [Google Scholar] [CrossRef] [PubMed]
  17. Ostos, F.J.; Lebrón, J.A.; López-Cornejo, P.; López-López, M.; García-Calderón, M.; García-Calderón, C.B.; Rosado, I.V.; Kalchenko, V.I.; Rodik, R.V.; Moyá, M.L. Self-aggregation in aqueous solution of amphiphilic cationic calix[4]arenes. Potential use as vectors and nanocarriers. J. Mol. Liq. 2020, 304, 112724. [Google Scholar] [CrossRef]
  18. Migliore, R.; Granata, G.; Rivoli, A.; Consoli, G.M.L.; Sgarlata, C. Binding Affinity and Driving Forces for the Interaction of Calixarene-Based Micellar Aggregates with Model Antibiotics in Neutral Aqueous Solution. Front. Chem. 2021, 8, 626467. [Google Scholar] [CrossRef]
  19. Nakai, T.; Kanamori, T.; Sando, S.; Aoyama, Y. Remarkably Size-Regulated Cell Invasion by Artificial Viruses. Saccharide-Dependent Self-Aggregation of Glycoviruses and Its Consequences in Glycoviral Gene Delivery. J. Am. Chem. Soc. 2003, 125, 8465–8475. [Google Scholar] [CrossRef]
  20. Shahgaldian, P.; Sciotti, M.A.; Pieles, U. Amino-Substituted Amphiphilic Calixarenes: Self-Assembly and Interactions with DNA. Langmuir 2008, 24, 8522–8526. [Google Scholar] [CrossRef]
  21. Nault, L.; Cumbo, A.; Pretôt, R.F.; Sciotti, M.A.; Shahgaldian, P. Cell transfection using layer-by-layer (LbL) coated calixarene-based solid lipid nanoparticles (SLNs). Chem. Commun. 2010, 46, 5581–5583. [Google Scholar] [CrossRef]
  22. Weeden, C.; Hartlieb, K.J.; Lim, L.Y. Preparation and physicochemical characterization of a novel paclitaxel-loaded amphiphilic aminocalixarene nanoparticle platform for anticancer chemotherapy. J. Pharm. Pharmacol. 2012, 64, 1403–1411. [Google Scholar] [CrossRef]
  23. Fatykhova, G.A.; Makarov, E.G.; Mironova, D.A.; Sultanova, E.D.; Burilov, V.A.; Solovieva, S.E.; Antipin, I.S. New Amphiphilic Calix[4]Arene Derivatives with 4,5-Dicarboxytriazolyl Fragments: Synthesis and Use in Micellar Catalysis. Russ. J. Phys. Chem. B 2019, 13, 401–407. [Google Scholar] [CrossRef]
  24. Burilov, V.; Makarov, E.; Mironova, D.; Sultanova, E.; Bilyukova, I.; Akyol, K.; Evtugyn, V.; Islamov, D.; Usachev, K.; Mukhametzyanov, T.; et al. Calix[4]arene Polyamine Triazoles: Synthesis, Aggregation and DNA Binding. Int. J. Mol. Sci. 2022, 23, 14889. [Google Scholar] [CrossRef] [PubMed]
  25. Gutsche, C.D.; Bauer, L.J. Calixarenes. 13. The conformational properties of calix[4]arenes, calix[6]arenes, calix[8]arenes, and oxacalixarenes. J. Am. Chem. Soc. 1985, 107, 6052–6059. [Google Scholar] [CrossRef]
  26. Aguiar, J.; Carpena, P.; Molina-Bolívar, J.A.; Carnero Ruiz, C. On the determination of the critical micelle concentration by the pyrene 1:3 ratio method. J. Colloid Interface Sci. 2003, 258, 116–122. [Google Scholar] [CrossRef]
  27. Mura, M.; Carucci, C.; Marincola, F.C.; Monduzzi, M.; Parsons, D.F.; Salis, A. The melting curves of calf thymus-DNA are buffer specific. J. Colloid Interface Sci. 2023, 630, 193–201. [Google Scholar] [CrossRef]
  28. Li, S.; Pan, J.; Zhang, G.; Xu, J.; Gong, D. Characterization of the groove binding between di-(2-ethylhexyl) phthalate and calf thymus DNA. Int. J. Biol. Macromol. 2017, 101, 736–746. [Google Scholar] [CrossRef]
  29. Lakowicz, J. Principles of Fluorescence Spectroscopy; Springer: New York, NY, USA, 2006. [Google Scholar] [CrossRef]
  30. Ross, P.D.; Subramanian, S. Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry 1981, 20, 3096–3102. [Google Scholar] [CrossRef]
  31. Fan, Y.; Wang, H.; He, C.; Qiao, F.; Wang, S.; Wang, Y. DNA Condensation Induced by a Star-Shaped Hexameric Cationic Surfactant. ACS Appl. Mater. Interfaces 2017, 9, 23333–23341. [Google Scholar] [CrossRef]
  32. Santos, D.; Medeiros-Silva, J.; Cegonho, S.; Alves, E.; Ramilo-Gomes, F.; Santos, A.O.; Silvestre, S.; Cruz, C. Cell proliferation effects of calix[4]arene derivatives. Tetrahedron 2015, 71, 7593–7599. [Google Scholar] [CrossRef]
  33. Méndez-Ardoy, A.; Gómez-García, M.; Mellet, C.O.; Sevillano, N.; Dolores Girón, M.; Salto, R.; Santoyo-González, F.; García Fernández, J.M. Preorganized macromolecular gene delivery systems: Amphiphilic β-cyclodextrin “click clusters”. Org. Biomol. Chem. 2009, 7, 2681–2684. [Google Scholar] [CrossRef] [PubMed]
  34. Gutsche, C.D.; Iqbal, M. p-tert-Butylcalix[4]arene. Org. Synth. 1990, 68, 234. [Google Scholar] [CrossRef]
  35. Zhang, T.-X.; Zhang, Z.-Z.; Yue, Y.-X.; Hu, X.-Y.; Huang, F.; Shi, L.; Liu, Y.; Guo, D.S. A General Hypoxia-Responsive Molecular Container for Tumor-Targeted Therapy. Adv. Mater. 2020, 32, 1908435. [Google Scholar] [CrossRef]
  36. Inman, R.B.; Jordan, D.O. The u.v.-absorption of calf-thymus DNA. Biochim. Biophys. Acta 1960, 42, 530–532. [Google Scholar] [CrossRef] [PubMed]
Scheme 1. Structures of previously synthesized macrocycles.
Scheme 1. Structures of previously synthesized macrocycles.
Pharmaceuticals 16 00699 sch001
Scheme 2. Synthetic approach for triazole derivatives containing monoamine fragments 78.
Scheme 2. Synthetic approach for triazole derivatives containing monoamine fragments 78.
Pharmaceuticals 16 00699 sch002
Figure 1. The UV absorption spectra for ct-DNA (50 μM), ct-DNA + calixarene complex (1:1) (a) 3; (b) 4; (c) 7; (d) 8.
Figure 1. The UV absorption spectra for ct-DNA (50 μM), ct-DNA + calixarene complex (1:1) (a) 3; (b) 4; (c) 7; (d) 8.
Pharmaceuticals 16 00699 g001aPharmaceuticals 16 00699 g001b
Figure 2. Melting curve for ct-DNA alone (50 μM) and in the presence of calixarenes (50 μM).
Figure 2. Melting curve for ct-DNA alone (50 μM) and in the presence of calixarenes (50 μM).
Pharmaceuticals 16 00699 g002
Figure 3. Emission spectra of the EtBr–ct-DNA system in the absence and presence of various concentrations of the macrocycles (a) 3; (b) 7; (c) 4; (d) 8 in 10 mM of Tris-HCl buffer solution with pH 7.4, (DNA) 50 μM.
Figure 3. Emission spectra of the EtBr–ct-DNA system in the absence and presence of various concentrations of the macrocycles (a) 3; (b) 7; (c) 4; (d) 8 in 10 mM of Tris-HCl buffer solution with pH 7.4, (DNA) 50 μM.
Pharmaceuticals 16 00699 g003
Figure 4. (a) The Stern–Volmer plot of ct-DNA titrated with macrocycles; (b) the plot of −log ((F0F)/F) versus −log(calixarene).
Figure 4. (a) The Stern–Volmer plot of ct-DNA titrated with macrocycles; (b) the plot of −log ((F0F)/F) versus −log(calixarene).
Pharmaceuticals 16 00699 g004
Figure 5. (a) Particle size of calixarene–DNA systems; (b) zeta potential of calixarene–DNA systems.
Figure 5. (a) Particle size of calixarene–DNA systems; (b) zeta potential of calixarene–DNA systems.
Pharmaceuticals 16 00699 g005
Figure 6. TEM images of (a) ct-DNA; (b) ct-DNA with 8; (c) ct-DNA with 4; (d) ct-DNA with 3.
Figure 6. TEM images of (a) ct-DNA; (b) ct-DNA with 8; (c) ct-DNA with 4; (d) ct-DNA with 3.
Pharmaceuticals 16 00699 g006
Figure 7. Graphs of cell viability of HSF (a), MCF7 (b) and PC-3 (c) cell lines treated with calixarenes 3 and 4.
Figure 7. Graphs of cell viability of HSF (a), MCF7 (b) and PC-3 (c) cell lines treated with calixarenes 3 and 4.
Pharmaceuticals 16 00699 g007
Table 1. Critical aggregation concentration (CAC) values, dynamic light scattering (DLS) and electrophoretic (ELS) data aggregates formed by calixarenes.
Table 1. Critical aggregation concentration (CAC) values, dynamic light scattering (DLS) and electrophoretic (ELS) data aggregates formed by calixarenes.
CalixareneCAC 1, μMD Average, nmd1, nm/(%)d2, nm/(%)PDIζ, mV
36.919 ± 114 ± 1 (66%)203 ± 25 (34%)0.536 ± 0.023+50 ± 4
4-264 ± 35--0.391 ± 0.132+51 ± 11
74.9150 ± 2--0.237 ± 0.012+47 ± 3
8-179 ± 12--0.216 ± 0.064+40 ± 5
1 (pyrene) 1 μM, (calixarene) 50 μM.
Table 2. The binding parameters obtained for the interactions of calixarenes with ct-DNA at 298.15 K.
Table 2. The binding parameters obtained for the interactions of calixarenes with ct-DNA at 298.15 K.
K s v ,   M 1 k q ,   M 1 s 1 R 2 ** S.D. K b ,   M 1 n R 2 S.D.
* ct-DNA + 3 4.0 × 10 5 4.0 × 10 13 0.98890.016 3.2 × 10 6 1.20.98990.32
ct-DNA + 4 1.8 × 10 5 1.8 × 10 13 0.98890.072 1.8 × 10 6 1.20.98980.31
ct-DNA + 7 5.7 × 10 2 5.7 × 10 10 0.96990.005----
ct-DNA + 8 6.9 × 10 4 6.9 × 10 12 0.98990.033 1.8 × 10 6 1.60.99890.25
* (ct-DNA) 50 μM; ** R 2 is the correlation coefficient. S.D. is the standard deviation.
Table 3. The thermodynamic parameters of binding between calixarenes with ct-DNA.
Table 3. The thermodynamic parameters of binding between calixarenes with ct-DNA.
Temperature, K K b ,   M 1 ΔH (kJ mol−1)ΔS (J mol−1 K−1)ΔG (kJ mol−1)
3
298.15 3.2 × 10 6 −3541314−746
304.15 9.8 × 10 6 −753
310.15 8.0 × 10 8 −761
4
298.15 1.8 × 10 6 −128550−292
304.15 3.9 × 10 6 −295
310.15 1.3 × 10 7 −299
8
298.15 1.8 × 10 6 −191761−418
304.15 7.7 × 10 6 −422
310.15 3.6 × 10 7 −427
Table 4. IC50 values (μM) for calixarenes.
Table 4. IC50 values (μM) for calixarenes.
3478
MCF73.83.3--
PC-319.37.4108.7-
HSF3.821.3--
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mironova, D.; Makarov, E.; Bilyukova, I.; Akyol, K.; Sultanova, E.; Evtugyn, V.; Davletshin, D.; Gilyazova, E.; Bulatov, E.; Burilov, V.; et al. Aggregation, Cytotoxicity and DNA Binding in a Series of Calix[4]arene Amphiphile Containing Aminotriazole Groups. Pharmaceuticals 2023, 16, 699. https://doi.org/10.3390/ph16050699

AMA Style

Mironova D, Makarov E, Bilyukova I, Akyol K, Sultanova E, Evtugyn V, Davletshin D, Gilyazova E, Bulatov E, Burilov V, et al. Aggregation, Cytotoxicity and DNA Binding in a Series of Calix[4]arene Amphiphile Containing Aminotriazole Groups. Pharmaceuticals. 2023; 16(5):699. https://doi.org/10.3390/ph16050699

Chicago/Turabian Style

Mironova, Diana, Egor Makarov, Islamiya Bilyukova, Kevser Akyol, Elsa Sultanova, Vladimir Evtugyn, Damir Davletshin, Elvina Gilyazova, Emil Bulatov, Vladimir Burilov, and et al. 2023. "Aggregation, Cytotoxicity and DNA Binding in a Series of Calix[4]arene Amphiphile Containing Aminotriazole Groups" Pharmaceuticals 16, no. 5: 699. https://doi.org/10.3390/ph16050699

APA Style

Mironova, D., Makarov, E., Bilyukova, I., Akyol, K., Sultanova, E., Evtugyn, V., Davletshin, D., Gilyazova, E., Bulatov, E., Burilov, V., Solovieva, S., & Antipin, I. (2023). Aggregation, Cytotoxicity and DNA Binding in a Series of Calix[4]arene Amphiphile Containing Aminotriazole Groups. Pharmaceuticals, 16(5), 699. https://doi.org/10.3390/ph16050699

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop